InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

Sector: Pharmaceutical Preparations Region: Canada

: | OTC Markets: IXSBF | TSX Venture Exchange: IXS.H

Similar to: Sanofi, Mast Therapeutics, Inc., Guerbet SA

InNexus Biotechnology, Inc. develops commercial opportunities based on the field of monoclonal antibodies, naturally occurring proteins that fight infection and disease, utilizing its proprietary DXL and Transmab technologies in three focus areas: ophthalmology, dermatology and oncology. The company was founded by Alton Charles Morgan on September 5, 1997 and is headquartered in Vancouver, Canada.

News & Analysis

You may also be interested in: